透云生物(01332)发布年度业绩，股东应占溢利2679.9万港元同比扭亏为盈

智通财经03-27

智通财经APP讯，透云生物(01332)发布截至2025年12月31日止年度业绩，该集团取得销售所提供货品及服务的收入7194.8万港元，同比减少21.74%;公司拥有人应占溢利2679.9万港元，去年同期则取得亏损8810.7万港元;每股盈利0.95港仙。公告称，年度溢利改善主要主要乃因按公平值计入损益的非持作买卖金融资产的公平值大幅获利。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2622587561?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-27 23:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622587561","market":"sh","top_or_hot":-1,"title":"透云生物(01332)发布年度业绩，股东应占溢利2679.9万港元 同比扭亏为盈","media":"智通财经","content":"<div>\n<p>智通财经APP讯，透云生物(01332)发布截至2025年12月31日止年度业绩，该集团取得销售所提供货品及服务的收入7194.8万港元，同比减少21.74%;公司拥有人应占溢利2679.9万港元，去年同期则取得亏损8810.7万港元;每股盈利0.95港仙。公告称，年度溢利改善主要主要乃因按公平值计入损益的非持作买卖金融资产的公平值大幅获利。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1421073.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>透云生物(01332)发布年度业绩，股东应占溢利2679.9万港元 同比扭亏为盈</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n透云生物(01332)发布年度业绩，股东应占溢利2679.9万港元 同比扭亏为盈\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-27 23:20 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1421073.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，透云生物(01332)发布截至2025年12月31日止年度业绩，该集团取得销售所提供货品及服务的收入7194.8万港元，同比减少21.74%;公司拥有人应占溢利2679.9万港元，去年同期则取得亏损8810.7万港元;每股盈利0.95港仙。公告称，年度溢利改善主要主要乃因按公平值计入损益的非持作买卖金融资产的公平值大幅获利。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1421073.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01332","symbol_name":"透云生物","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1421073.html","article_id":"2622587561","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622587561","pubTimestamp":1774624853,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，透云生物(01332)发布截至2025年12月31日止年度业绩，该集团取得销售所提供货品及服务的收入7194.8万港元，同比减少21.74%;公司拥有人应占溢利2679.9万港元，去年同期则取得亏损8810.7万港元;每股盈利0.95港仙。公告称，年度溢利改善主要主要乃因按公平值计入损益的非持作买卖金融资产的公平值大幅获利。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"01332":"透云生物","BK1157":"纸材料包装"},"translate_title":"Touyun Biotech (01332) released its annual results, and the profit attributable to shareholders was HK$26.799 million, turning loss into profit year-on-year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01332":1.5},"content_text":"智通财经APP讯，透云生物(01332)发布截至2025年12月31日止年度业绩，该集团取得销售所提供货品及服务的收入7194.8万港元，同比减少21.74%;公司拥有人应占溢利2679.9万港元，去年同期则取得亏损8810.7万港元;每股盈利0.95港仙。公告称，年度溢利改善主要主要乃因按公平值计入损益的非持作买卖金融资产的公平值大幅获利。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622587561","isCrawlerRequest":true}

透云生物(01332)发布年度业绩，股东应占溢利2679.9万港元 同比扭亏为盈

精彩评论

透云生物(01332)发布年度业绩，股东应占溢利2679.9万港元同比扭亏为盈